Progress in primary aldosteronism: present challenges and perspectives
- PMID: 20091458
- PMCID: PMC4823770
- DOI: 10.1055/s-0029-1243619
Progress in primary aldosteronism: present challenges and perspectives
Abstract
Primary Aldosteronism (PA) is a disorder of the adrenal zona glomerulosa (ZG) in which aldosterone secretion is increased and is relatively autonomous of normal regulatory mechanisms. A recent conference in Munich organized by Prof. Reincke addressed advances and challenges related to the screening, diagnosis, and identification of uni- and bilateral involvement of the diseased adrenal of PA. Some infrequently addressed issues are described herein. We postulate that most cases of PA are due to the activation by unknown mechanisms of subset of cells resulting in the formation of a multiple foci or nodules of hyperactive zona glomerulosa cells. This implies that one or several yet unidentified stimuli can drive aldosterone overproduction, as well as the proliferation of aldosterone-producing cells. Current diagnostic procedures allow to determine whether inappropriate aldosterone production is driven by one or both adrenal glands and thus to establish optimal treatment.
Georg Thieme Verlag KG Stuttgart-New York.
Similar articles
-
Progress in primary aldosteronism.Horm Metab Res. 2010 Jun;42(6):371-3. doi: 10.1055/s-0030-1253417. Epub 2010 May 25. Horm Metab Res. 2010. PMID: 20503135 No abstract available.
-
[Primary aldosteronism caused by aldosteronoma: problems in the etiologic diagnosis].Arq Bras Endocrinol Metabol. 2007 Apr;51(3):478-87. doi: 10.1590/s0004-27302007000300018. Arq Bras Endocrinol Metabol. 2007. PMID: 17546249 Portuguese.
-
Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma.Hypertension. 2012 Aug;60(2):431-6. doi: 10.1161/HYPERTENSIONAHA.112.195891. Epub 2012 Jun 25. Hypertension. 2012. PMID: 22733469
-
Primary aldosteronism: challenges in diagnosis and management.Endocrinol Metab Clin North Am. 2015 Jun;44(2):355-69. doi: 10.1016/j.ecl.2015.02.010. Endocrinol Metab Clin North Am. 2015. PMID: 26038205 Review.
-
Recent advances in diagnosis and treatment of primary aldosteronism.Minerva Med. 2003 Aug;94(4):259-65. Minerva Med. 2003. PMID: 14605590 Review.
Cited by
-
Mineralocorticoid receptors in the brain and cardiovascular regulation: minority rule?Trends Endocrinol Metab. 2011 May;22(5):179-87. doi: 10.1016/j.tem.2011.02.001. Epub 2011 Mar 21. Trends Endocrinol Metab. 2011. PMID: 21429762 Free PMC article. Review.
-
Comparison of aldosterone production among human adrenocortical cell lines.Horm Metab Res. 2012 Mar;44(3):245-50. doi: 10.1055/s-0031-1298019. Epub 2012 Jan 20. Horm Metab Res. 2012. PMID: 22266826 Free PMC article.
-
Immunohistopathology and Steroid Profiles Associated With Biochemical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism.Hypertension. 2018 Sep;72(3):650-657. doi: 10.1161/HYPERTENSIONAHA.118.11465. Hypertension. 2018. PMID: 30012870 Free PMC article.
-
Third-generation Mineralocorticoid Receptor Antagonists: Why Do We Need a Fourth?J Cardiovasc Pharmacol. 2016 Jan;67(1):26-38. doi: 10.1097/FJC.0000000000000329. J Cardiovasc Pharmacol. 2016. PMID: 26466326 Free PMC article. Review.
-
Circulating miRNA Expression Profiling in Primary Aldosteronism.Front Endocrinol (Lausanne). 2019 Oct 29;10:739. doi: 10.3389/fendo.2019.00739. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31736877 Free PMC article.
References
-
- Conn JW. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med. 1955;45:3–7. - PubMed
-
- Conn JW, Knopf RF, Nesbit RM. Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am J Surg. 1964;107:159–172. - PubMed
-
- Conn JW, Cohen EL, Rovner DR, Nesbit RM. Normokalemic primary aldosteronism. A detectable cause of curable “essential” hypertension. JAMA. 1965;193:200–206. - PubMed
-
- Andersen GS, Toftdahl DB, Lund JO, Strandgaard S, Nielsen PE. The incidence rate of phaeochromocytoma and Conns syndrome in Denmark, 1977–1981. J Hum Hypertens. 1988;2:187–189. - PubMed
-
- Kaplan NM. Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism. Ann Int Med. 1967;66:1079–1090. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources